Titan Bio-Tech Announces 1:2 Bonus Issue; Record Date Set for October 23, 2026

Titan Bio-Tech Limited has announced a 1:2 bonus share issue, offering shareholders one free equity share for every two existing shares held.

According to a BSE notice dated October 13, 2026, the company has fixed October 23, 2026, as the record date to determine shareholder eligibility.

What Does the 1:2 Bonus Issue Mean for Shareholders?

Under the 1:2 bonus ratio, investors will receive one additional equity share for every two shares they own.

For example, an investor holding 100 shares of Titan Bio-Tech will receive 50 bonus shares, increasing their total holding to 150 shares.

However, a bonus issue does not automatically increase the value of an investment, as the stock price generally adjusts proportionately on the ex-bonus date.

When Will Titan Bio-Tech Bonus Shares Be Credited?

According to the BSE announcement, the company has indicated October 23, 2026, as the deemed date of allotment, with the bonus shares expected to be allotted on October 26, 2026, subject to the applicable corporate action process.

Investors should monitor their demat accounts and exchange announcements for confirmation of the credit and trading dates.

Key Takeaways

- Titan Bio-Tech has announced a 1:2 bonus issue.
- The record date and ex-bonus date are October 23, 2026.
- Shareholders will receive one bonus share for every two shares held.
- The bonus issue increases the number of shares held without changing the investor's proportionate ownership.

Investors can track the latest bonus issues, stock splits, dividends and other corporate actions on ArihantPlus.